Recombinant HAV P2C Protein (a.a. 1121-1234)

Product Overview

The E.Coli derived recombinant 38.5 kDa protein contains the P2C immunodominant regions, amino acids 1121-1234.

Nature

Recombinant

Tag/Conjugate

Unconjugated

Purity

> 90%, based on SDS PAGE

Format

Each vial contains 100 μg of lyophilized protein in 10mM CBB, pH9.6, 0.1% SDS and 50% glycerol.

Preservative

None

Storage

2-8°C short term, -20°C long term

Introduction

Hepatitis A virus (HAV) is the sole member of the Hepatovirus genus within the family Picornaviridae. The capsid of HAV encloses a single-stranded RNA genome of about 7.5 kb which is translated into a single polyprotein. The virion proteins VP1 to VP4 and the nonstructural proteins are generated from the polyprotein by a cascade of proteolytic cleavages. Only one protease, viral protease 3C, has been implicated in the nine protein scissions. Processing of the capsid protein precursor region generates a unique intermediate, PX (VP1-2A), which accumulates in infected cells and is assumed to serve as precursor to VP1 found in virions, although the details of this reaction have not been determined. Capsid proteins VP1, VP2, and VP3 form a closed capsid enclosing the viral positive strand RNA genome. VP1 is a major viral antigen.

Antigen Description

Protein 2C associates with and induces structural rearrangements of intracellular membranes. It displays RNA-binding, nucleotide binding and NTPase activities (By similarity)

Keywords

HAV P2C ; Hepatitis A P2C